Môi giới chuyên nghiệp
Đăng xuất
|
THE MINISTRY OF
HEALTH OF VIETNAM |
THE SOCIALIST
REPUBLIC OF VIETNAM |
|
No. 11/VBHN-BYT |
Hanoi, November 02, 2023 |
PRESCRIBING MANAGEMENT OF FUNCTIONAL FOODS
The Circular No. 43/2014/TT-BYT dated November 24, 2014 of the Minister of Health prescribing management of functional foods, coming into force from February 01, 2015, is amended by:
The Circular No. 17/2023/TT-BYT dated September 25, 2023 of the Minister of Health of Vietnam providing amendments to and abrogation of some legislative documents on food safety, coming into force from November 09, 2023.
Pursuant to the Law on Food Safety dated June 17, 2010;
Pursuant to the Government's Decree No. 38/2012/ND-CP dated April 25, 2012 elaborating the Law of Food Safety;
Pursuant to the Government’s Decree No. 63/2012/ND-CP dated August 31, 2012 defining functions, tasks, powers and organizational structure of the Ministry of Health of Vietnam;
At the request of the Director of Vietnam Food Administration;
The Minister of Health of Vietnam promulgates a Circular providing regulations on management of functional foods. [1]
Article 1. Scope and regulated entities
1. This Circular provides for the activities relating to production, trading, product declaration, labeling and provision of instructions for use of functional foods such as supplemented foods, health supplements and medical foods, including foods for special dietary uses.
2. This Circular does not apply to nutritional formulas for children. Production, trading, product declaration, labeling and provision of instructions for use of these products shall comply with corresponding technical regulations and regulations of law on trading and use of nutritional products for children.
For the purposes of this Circular, the terms below shall be construed as follows:
1. “supplemented food” means a normal food that is supplemented with micronutrients and other ingredients food for health such as vitamins, minerals, amino acids, fatty acids, enzymes, probiotics, prebiotics and other biologically active substances.
2 [2]. (abrogated)
3[3]. (abrogated).
4 [4]. (abrogated).
5[5]. (abrogated).
6. Recommended nutrition intake (RNI) for Vietnamese means the intake level of a particular nutrient considered sufficient for Vietnamese people as recommended by the National Institute of Nutrition (affiliated to the Ministry of Health of Vietnam).
GENERAL REQUIREMENTS FOR FUNCTIONAL FOODS
Article 3. Product self-declaration and registration of product disclosure [6]
1[7]. (abrogated).
2[8]. (abrogated).
3[9]. Procedures for product self-declaration and registration of product disclosure:
a) Procedures for product self-declaration are laid down in Chapter II of the Government’s Decree No. 15/2018/ND-CP dated February 02, 2018 on elaboration of the Law on Food Safety and clause 1 Article 3 Chapter I of the Government’s Decree No. 155/2018/ND-CP dated November 12, 2018 providing amendments to regulations on investment and business conditions in sectors under the state management of the Ministry of Health of Vietnam;
b) Procedures for registration of product disclosure are laid down in Chapter III of the Government’s Decree No. 15/2018/ND-CP dated February 02, 2018.
Article 4. Requirements attached to efficacy testing reports
1. Effects on human health of the following products must be tested:
a[10]) (abrogated)
b) Products whose new effects are disclosed but have not yet been recognized by any countries in the world;
c) Products containing new active ingredients the use of which is not yet permitted;
d) Health supplements which are put on the market for the first time and have formulas different from those of products supported by adequate scientific evidences;
dd) Products derived from plants/animals and put on the market for the first time, the composition of which is different from that of the ancient traditional remedy or dose-adjusted ancient traditional remedy products published in academic journals;
e) Medical foods and foods for special dietary uses which have not been permitted by competent authorities or authorized authorities or law of the country of origin, or the effects, suitable users and usage instructions on the label have not been confirmed by the exporting country.
2[11]. The test for effects on human health must be conducted in accordance with regulations on biomedical research involving human participants laid down in the Circular No. 04/2020/TT-BYT dated March 05, 2020 of the Minister of Health of Vietnam prescribing establishment, functions, tasks, and rights of Research Ethics Committees, and procedures and regulations of the Law on Science and Technology.
3. If the test for the effects on human health is conducted overseas, it must be performed by entities accredited by competent authorities of home country.
4[12]. Any issue that arises beyond the scope of this Circular shall be reported by the receiving authority to its supervisory authority for timely resolution, taking into account the following factors: compliance with relevant laws and regulations, assurance of the health and interests of consumers, and no influence on food production and trading of organizations and individuals.
REQUIREMENTS FOR FUNCTIONAL FODOS
Article 8. Requirements regarding claims
1. Nutrient content claims:
When supplementing foods with vitamins, minerals, amino acids, fatty acids, enzymes, probiotics, prebiotics or other biologically active substances, the claims about the contents of such substances in foods according to recommended nutrition intakes (RNI) for Vietnamese are specified in Appendix No. 01 enclosed herewith as follows:
a) [16] A substance shall not be mentioned if its content is below 10% RNI or 10% of the intake of that substance stated in a given scientific evidence (for a substance for which the RNI is not disclosed);
b) [17] If the content of a substance reaches at least 10% RNI or at least 10% of the intake of that substance stated in a given scientific evidence (for a substance for which the RNI is not disclosed), its name and its content in a serving or 100g of the product shall be specified;
c) The maximum contents of vitamins and minerals in foods according to RNI levels provided by manufacturers shall not exceed the tolerable upper intake levels of such vitamins and minerals specified in Appendix 02 enclosed herewith.
If RNI levels and tolerable upper intake levels of Vietnam are not available, they shall be determined according to regulations of CODEX or relevant international organizations.
2. Health claims:
a) [18] Health claims about a supplemental substance shall be made only when its content in the food reaches 10% RNI or above and is proven with specific scientific evidence;
b) [19] Regarding a supplemental ingredient for which RNI level is yet to be announced, health claims shall be made on the product’s label only when its content reaches at least 10% of its intake stated in the given scientific evidence;
c) [20] Health claims must be clear, consistent, and suitable for the given scientific evidence;
Article 10. Requirements regarding claims
1. Contain claims:
a) [22] (abrogated);
b) [23] The content of vitamins or minerals in foods according to RNI levels provided by manufacturers shall reach at least 15% of RNI levels for Vietnamese or at least 15% of their intakes stated in the given scientific evidence;
c) The maximum contents of vitamins and minerals in foods according to RNI levels provided by manufacturers shall not exceed the tolerable upper intake levels of such vitamins and minerals specified in Appendix 02 enclosed herewith;
d) [24] If RNI levels and tolerable upper intake levels of Vietnam are not available, they shall be determined according to regulations of CODEX or relevant international organizations.
2. Health claims:
a) Health claims must reflect the product nature. The claim about effects of ingredients having main or combined effects shall be made only when there is scientific evidence. The effects of ingredients must not be enumerated as effects of the product;
b) Claims about health, dose, suitable users and usage instructions must be consistent and in conformity with the documents;
c) [25] (abrogated)
d) [26] If the contents of vitamins and minerals in a product and reach at least 15% RNI or at least 15% of their intakes stated in the given scientific evidence, their effects shall be claimed, provided suitable users and doses are specified;
dd) [27] If the daily intake of an ingredient for which the RNI level is yet to be announced reaches at least 15% of its intake stated in the given scientific evidence, its effects shall be claimed, provided suitable users and doses are specified.
3. Users:
a) [28] The suitable users must be determined in conformity with claimed effects and approved by the authority receiving the application for registration of product disclosure by giving certification of product disclosure;
b) Prohibited users (if any) must be specified.
[29] Labeling of health supplements must comply with regulations on labeling and the following provisions:
1[30]. (abrogated)
2[31]. (abrogated)
3. Mechanism of action of the product shall not be written on its label.
4[32]. The phrase “Thực phẩm này không phải là thuốc và không có tác dụng thay thế thuốc chữa bệnh” (“This food is not a medicine, and is not a substitute for medicines”) shall be specified on the label right after the product’s effects or with other claims (if any).
MEDICAL FOODS AND FOODS FOR SPECIAL DIETARY USES
Article 12. Requirements regarding claims
1. Nutrient content claims:
a) [33] (abrogated);
b) RNI levels of vitamins and minerals in a serving or their contents in 100g product must be specified;
c) The maximum contents of vitamins and minerals in foods according to RNI levels provided by manufacturers shall not exceed the tolerable upper intake levels of such vitamins and minerals specified in Appendix 02 enclosed herewith.
If RNI levels and tolerable upper intake levels of Vietnam are not available, they shall be determined according to regulations of CODEX or relevant international organizations.
2. Health claims:
The health claims must specify the RNI levels applied to various users.
3. Users:
The product claims must specify the suitable users and prohibited users (if any).
4. Dose:
The dose for each specific user for a given period of time must be specified.
CONDITIONS FOR PRODUCTION, TRADING AND INSTRUCTIONS FOR USE OF FUNCTIONAL FOODS [35]
RECALL AND DISPOSAL OF UNSAFE FUNCTIONAL FOODS [38]
This Circular comes into force from February 01, 2015.
The Circular No. 08/2004/TT-BYT dated August 23, 2004 of the Minister of Health of Vietnam providing guidelines for management of functional foods is abrogated from the date of entry into force of this Circular.
Certificate of Declaration of Conformity or Certificate of submission of Declaration of Conformity with food safety regulations granted to a functional food before the effective date of this Circular shall still remain valid until its expiry date.
Article 21. Implementation organization
1. Vietnam Food Administration affiliated to the Ministry of Health of Vietnam plays the leading role and cooperate with functional authorities of the Ministry of Industry and Trade of Vietnam and the Ministry of Public Security of Vietnam, within the ambit of their assigned power, in organizing, directing, inspecting and monitoring the implementation of this Circular.
2. Provincial Departments of Health shall organize, and direct branches of Vietnam Food Administration and relevant authorities to carry out, inspection and supervision of local manufacturers and traders of functional foods.
3. Authorities, organizations or individuals having products whose effects on human health need to be tested shall pay testing costs in accordance with current regulations.
4. Manufacturers and traders of functional foods are responsible for implementation of this Circular.
Difficulties that arise during the implementation of this Circular should be reported to the Ministry of Health of Vietnam (via Vietnam Food Administration) for consideration./.
|
|
CERTIFIED BY PP. MINISTER |
TABLE OF RECOMMENDED NUTRITION INTAKES (RNI) FOR
VIETNAMESE
(Enclosed with the Circular No. 43/2014/TT-BYT dated November 24, 2014 of
the Minister of Health of Vietnam)
1. RNI levels of minerals and micronutrients
|
Age and gender |
Ca (Calcium) (mg/day) |
Mg (Magnesium) (mg/day) |
P (Phosphorus) (mg/day) |
Selenium * (μg/day) |
|
Infants |
|
|
|
|
|
< 6 months old |
300 |
36 |
90 |
6 |
|
6-11 months old |
400 |
54 |
275 |
10 |
|
Children |
|
|
|
|
|
1-3 years old |
500 |
65 |
460 |
17 |
|
4-6 years old |
600 |
76 |
500 |
22 |
|
7-9 years old |
700 |
100 |
500 |
21 |
|
Adolescents (male) |
|
|
|
|
|
10-12 years old |
1.000 |
155 |
1.250 |
32 |
|
13-15 years old |
225 |
|||
|
16-18 years old |
260 |
|||
|
Adults (male) |
|
|
|
|
|
19-49 years old |
700 |
205 |
700 |
34 |
|
50-60 years old |
1.000 |
|||
|
> 60 years old |
33 |
|||
|
Adolescents (female) |
|
|
|
|
|
10-12 years old (under the age of menstruation) |
1.000 |
160 |
1.250 |
26 |
|
10-12 years old |
||||
|
13-15 years old |
220 |
|||
|
16-18 years old |
240 |
|||
|
Adults (female) |
|
|
|
|
|
19-49 years old |
700 |
205 |
700 |
26 |
|
50-60 years old |
1.000 |
|||
|
> 60 years old |
25 |
|||
|
Pregnant women |
|
|
|
|
|
First trimester |
1.000 |
205 |
700 |
26 |
|
Second trimester |
28 |
|||
|
Third trimester |
30 |
|||
|
Breastfeeding women (during breastfeeding period) |
1.000 |
250 |
700 |
|
|
First 6 months |
|
|
|
35 |
|
Last 6 months |
|
|
|
42 |
* RNI levels are determined according to the average intakes +2 SD.
2. RNI levels of iodine, iron and zinc
|
Age |
Iodine |
Iron (mg/day) according to biological value |
Zinc (mg/day) |
|||||
|
5%1 |
10%2 |
15%3 |
High absorption |
Average absorption |
Poor absorption |
|||
|
Infants |
||||||||
|
0-6 months old |
90 |
0,93 |
|
|
1,15 |
2,86 |
6,57 |
|
|
6-11 months old |
90 |
18,6 |
12,4 |
9,3 |
0,8-2,58 |
4,18 |
8,38 |
|
|
Children |
||||||||
|
1-3 years old |
90 |
11,6 |
7,7 |
5,8 |
2,4 |
4,1 |
8,4 |
|
|
4-6 years old |
90 |
12,6 |
8,4 |
6,3 |
3,1 |
5,1 |
10,3 |
|
|
7-9 years old |
90 |
17,8 |
11,9 |
8,9 |
3,3 |
5,6 |
11,3 |
|
|
Adolescents (male) |
||||||||
|
10-14 years old |
120 |
29,2 |
19,5 |
14,6 |
5,7 |
9,7 |
19,2 |
|
|
15-18 years old |
150 |
37,6 |
25,1 |
18,8 |
5,7 |
9,7 |
19,2 |
|
|
Adolescents (female) |
||||||||
|
10-14 years old |
120 |
28,0 |
18,7 |
14,0 |
4,6 |
7,8 |
15,5 |
|
|
15-18 years old |
150 |
65,4 |
43,6 |
32,7 |
4,6 |
7,8 |
15,5 |
|
|
Adults |
||||||||
|
Male, ≥ 19 years old |
150 |
27,4 |
18,3 |
13,7 |
4,2 |
7,0 |
14,0 |
|
|
Female, ≥ 19 years old |
150 |
58,8 |
39,2 |
29,4 |
3,0 |
4,9 |
9,8 |
|
|
Middle-aged adults (≥ 50 years old) |
||||||||
|
Male |
|
|
|
|
3,0 |
4,9 |
9,8 |
|
|
Female |
|
22,6 |
15,1 |
11,3 |
3,0 |
4,9 |
9,8 |
|
|
Pregnant women |
200 |
+30,04 |
+20,04 |
+15,04 |
|
|
|
|
|
Breastfeeding women |
200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Serving size with low biological value of iron (about 5% of iron is absorbed): simple and monotonous regimen, containing under 30g of meat and/or fish per day or under 25 mg of vitamin C per day.
2 Serving size with average biological value of iron (about 10% of iron is absorbed): containing 30g – 90g of meat and/or fish per day or 25 mg – 75 mg of vitamin C per day.
3 Serving size with high biological value of iron (about 15% of iron is absorbed): containing over 90g of meat and/or fish per day or over 75 mg of vitamin C per day.
4 Pregnant women are recommended to take iron pills during the gestation. A pregnant woman with anaemia should take a higher dose.
5 Breast-fed children
6 Formula-fed children
7 Children fed by formula milk with great amount plant-based protein and phytates
8 Excluding purely breast-fed children
8 High absorption: high biological value of zinc, equal to 50% (serving contains a lot of protein from animal or fish derivatives); average absorption: average biological value of zinc, equal to 30% (serving contains an average amount of protein from animal or fish derivatives; ratio of phytate and zinc is at 5:15); low absorption: low biological value of zinc, equal to 15% (serving contains very little or does not contain protein from animal or fish derivatives).
|
Age and gender |
A mcga |
D mcgc |
E mgd |
K mcg |
C mgb |
B1 mg |
B2 mg |
B3 mg NEe |
B6 mg |
B9 mcgf |
B12 mcg |
|
|
Infants and children |
|
|||||||||||
|
< 6 months old |
375 |
5 |
3 |
6 |
25 |
0,2 |
0,3 |
2 |
0,1 |
80 |
0,3 |
|
|
6-11 months old |
400 |
5 |
4 |
9 |
30 |
0,3 |
0,4 |
4 |
0,3 |
80 |
0,4 |
|
|
1-3 years old |
400 |
5 |
5 |
13 |
30 |
0,5 |
0,5 |
6 |
0,5 |
160 |
0,9 |
|
|
4-6 years old |
450 |
5 |
6 |
19 |
30 |
0,6 |
0,6 |
8 |
0,6 |
200 |
1,2 |
|
|
7-9 years old |
500 |
5 |
7 |
24 |
35 |
0,9 |
0,9 |
12 |
1 |
300 |
1,8 |
|
|
Adolescents (male) |
|
|||||||||||
|
10-12 years old |
600 |
5 |
10 |
34 |
65 |
1,2 |
1,3 |
16 |
1,3 |
400 |
2,4 |
|
|
13-15 years old |
12 |
50 |
|
|||||||||
|
16-18 years old |
13 |
58 |
|
|||||||||
|
Adults (male) |
|
|||||||||||
|
19-50 years old |
600 |
10 |
12 |
59 |
70 |
1,2 |
1,3 |
16 |
1,3 |
400 |
2,4 |
|
|
51-60 years old |
10 |
|
1,7 |
|
||||||||
|
≥60 years old |
15 |
|
|
|||||||||
|
Adolescents (female) |
|
|||||||||||
|
10-12 years old |
600 |
5 |
11 |
35 |
65 |
1,1 |
1 |
16 |
1,2 |
400 |
2,4 |
|
|
13-15 years old |
12 |
49 |
|
|||||||||
|
16-18 years old |
12 |
50 |
|
|||||||||
|
Adults (female) |
|
|||||||||||
|
19-50 years old |
500 |
10 |
12 |
51 |
70 |
1,2 |
1,1 |
14 |
1,3 |
400 |
2,4 |
|
|
51-60 years old |
10 |
|
1,1 |
1,5 |
|
|||||||
|
> 60 years old |
600 |
15 |
|
70 |
1,1 |
|
||||||
|
Pregnant women |
800 |
5 |
12 |
51 |
80 |
1,4 |
1,4 |
18 |
1,9 |
600 |
2,6 |
|
|
Breastfeeding women |
850 |
5 |
18 |
51 |
95 |
1,5 |
1,6 |
17 |
2 |
500 |
2,8 |
|
a These following conversion factors may be used for vitamin A:
01 mcg of vitamin A or retinol = 01 retinol equivalent (RE)
01 IU (International unit) is equivalent to 0.3 mcg of vitamin A
01 mcg of b-carotene = 0.167 mcg of vitamin A
01 mcg of other carotenes = 0.084 mcg of vitamin A
b Excluding the loss during processing and cooking activities because Vitamin C is destroyed easily by the oxidization, light, alkali and temperature.
c These following conversion factors may be used for vitamin D:
01 IU is equivalent to 0.03 mcg of vitamin D3, or 01 mcg of vitamin D3 = 40 IU
d IU conversion factors (according to IOM-FNB 2000): 01 mg a-tocopherol = 1 IU; 01 mg b-tocopherol = 0,5 IU; 01 mg g-tocopherol = 0,1 IU; 0,1 mg s-tocopherol = 0,02 IU.
e Niacin or Niacin equivalent
f These following conversion factors may be used for Folic acid:
01 folic acid = 1 folate x 1.7, or 01 g of folic acid equivalent = 01 g of folate in food + (1.7 x amount of synthetic folic acid (in gram)).
Note: This table will be updated according to current regulations of the Ministry of Health of Vietnam.
TOLERABLE UPPER INTAKE LEVELS
(Enclosed with the Circular No. 43/2014/TT-BYT dated November 24, 2014 of
the Minister of Health of Vietnam)
|
Age |
Vitamin A (μg/day) |
Vitamin C (mg/day) |
Vitamin D (μg/day) |
Vitamin E |
Vitamin K (μg/day) |
Vitamin B1 (mg/day) |
Riboflavin (mg/day) |
Niacin (mg/day) |
Vitamin B6 (mg/day) |
Acid Folic (μg/day) |
Vitamin B12 (μg/day) |
Pantothenic (mg/day) |
Biotin (μg/day) |
|
Infants |
|||||||||||||
|
0-6 months old |
600 |
N/A |
25 |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
|
6-12 months old |
600 |
N/A |
38 |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
|
Children |
|||||||||||||
|
1-3 years old |
600 |
400 |
63 |
200 |
N/A |
N/A |
N/A |
10 |
30 |
300 |
N/A |
N/A |
N/A |
|
4-8 years old |
900 |
650 |
75 |
300 |
N/A |
N/A |
N/A |
15 |
40 |
400 |
N/A |
N/A |
N/A |
|
Teenagers (9-13 years old) |
|||||||||||||
|
Male |
1.700 |
1.200 |
100 |
600 |
N/A |
N/A |
N/A |
20 |
60 |
600 |
N/A |
N/A |
N/A |
|
Female |
1.700 |
1.200 |
100 |
600 |
N/A |
N/A |
N/A |
20 |
60 |
600 |
N/A |
N/A |
N/A |
|
Adolescents (14-18 years old) |
|||||||||||||
|
Male |
2.800 |
1.800 |
100 |
800 |
N/A |
N/A |
N/A |
30 |
80 |
800 |
N/A |
N/A |
N/A |
|
Female |
2.800 |
1.800 |
100 |
800 |
N/A |
N/A |
N/A |
30 |
80 |
800 |
N/A |
N/A |
N/A |
|
Adults, ≥ 19 years old |
|||||||||||||
|
Male |
3.000 |
2.000 |
100 |
1.000 |
N/A |
N/A |
N/A |
35 |
100 |
1.000 |
N/A |
N/A |
N/A |
|
Female |
3.000 |
2.000 |
100 |
1.000 |
N/A |
N/A |
N/A |
35 |
100 |
1.000 |
N/A |
N/A |
N/A |
|
Old people, ≥ 51 years old |
|||||||||||||
|
Male |
3.000 |
2.000 |
100 |
1.000 |
N/A |
N/A |
N/A |
35 |
100 |
1.000 |
N/A |
N/A |
N/A |
|
Female |
3.000 |
2.000 |
100 |
1.000 |
N/A |
N/A |
N/A |
35 |
100 |
1.000 |
N/A |
N/A |
N/A |
|
Pregnant women |
3.000 |
2.000 |
100 |
1.000 |
N/A |
N/A |
N/A |
35 |
100 |
1.000 |
N/A |
N/A |
N/A |
|
Breastfeeding women |
3.000 |
2.000 |
100 |
1.000 |
N/A |
N/A |
N/A |
35 |
100 |
1.000 |
N/A |
N/A |
N/A |
|
Age |
Arsenic |
Boron (mg/day) |
Chronium |
Copper (μg/day) |
Fluoride (mg/day) |
Iodine |
Iron |
Magnesium |
Manganese |
Molybdenum (μg/day) |
Nickel |
Selenium |
Zinc (mg/day) |
|||||||||
|
Infants |
||||||||||||||||||||||
|
0-6 months old |
N/A |
N/A |
N/A |
N/A |
0,7 |
N/A |
40 |
N/A |
N/A |
N/A |
N/A |
45 |
4 |
|||||||||
|
6-12 months old |
N/A |
N/A |
N/A |
N/A |
0,9 |
N/A |
40 |
N/A |
N/A |
N/A |
N/A |
60 |
5 |
|||||||||
|
Children |
||||||||||||||||||||||
|
1-3 years old |
N/A |
3 |
N/A |
1.000 |
1,3 |
200 |
40 |
65 |
2 |
300 |
0,2 |
90 |
7 |
|||||||||
|
4-8 years old |
N/A |
6 |
N/A |
3.000 |
2,2 |
300 |
40 |
110 |
3 |
600 |
0,3 |
150 |
12 |
|||||||||
|
Teenagers (9-13 years old) |
||||||||||||||||||||||
|
Male |
N/A |
11 |
N/A |
5.000 |
10 |
600 |
40 |
350 |
9 |
1.100 |
0,6 |
280 |
23 |
|||||||||
|
Female |
N/A |
11 |
N/A |
5.000 |
10 |
600 |
40 |
350 |
9 |
1.100 |
0,6 |
280 |
23 |
|||||||||
|
Adolescents (14-18 years old) |
||||||||||||||||||||||
|
Male |
N/A |
17 |
N/A |
8.000 |
10 |
900 |
45 |
350 |
11 |
1.700 |
1,0 |
400 |
34 |
|||||||||
|
Female |
N/A |
17 |
N/A |
8.000 |
10 |
900 |
45 |
350 |
11 |
1.700 |
1,0 |
400 |
34 |
|||||||||
|
Adults, ≥ 19 years old |
||||||||||||||||||||||
|
Male |
N/A |
20 |
N/A |
10.000 |
10 |
1.100 |
45 |
350 |
11 |
2.000 |
1,0 |
400 |
40 |
|||||||||
|
Female |
N/A |
20 |
N/A |
10.000 |
10 |
1.100 |
45 |
350 |
11 |
2.000 |
1,0 |
400 |
40 |
|||||||||
|
Old people, ≥ 51 years old |
||||||||||||||||||||||
|
Male |
N/A |
20 |
N/A |
10.000 |
10 |
1.100 |
45 |
350 |
11 |
2.000 |
1,0 |
400 |
40 |
|||||||||
|
Female |
N/A |
20 |
N/A |
10.000 |
10 |
1 100 |
45 |
350 |
11 |
2.000 |
1,0 |
400 |
40 |
|||||||||
|
Pregnant women |
N/A |
20 |
N/A |
10.000 |
10 |
1.100 |
45 |
350 |
11 |
2.000 |
1,0 |
400 |
40 |
|||||||||
|
Breastfeeding women |
N/A |
20 |
N/A |
10.000 |
10 |
1.100 |
45 |
350 |
11 |
2.000 |
1,0 |
400 |
40 |
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tolerable upper intake level means the highest level of micronutrient intake that is likely to cause no poison or pose no risk of adverse health effects.
N/A: There is not enough information to determine the tolerable upper intake level
Note: This table will be updated according to current regulations of the Ministry of Health of Vietnam.
[1] The Circular No. 17/2023/TT-BYT dated September 25, 2023 of the Minister of Health of Vietnam providing amendments to and abrogation of some legislative documents on food safety is promulgated pursuant to:
The Law on Promulgation of Legislative Documents No. 80/2015/QH13 dated June 22, 2015 and the Law on amendments to the Law on Promulgation of Legislative Documents No. 63/2020/QH14 dated June 18, 2020;
The Law on Food Safety No. 55/2010/QH12 dated June 17, 2010;
The Government's Decree No. 15/2018/ND-CP dated February 02, 2018 on elaboration of the Law on Food Safety;
The Government’s Decree No. 95/2022/ND-CP dated November 15, 2022 defining functions, tasks, powers and organizational structure of the Ministry of Health of Vietnam;
And at the request of the Director of Vietnam Food Administration,”
[2] This clause is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[3] This clause is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[4] This clause is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[5] This clause is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[6] This Article is amended according to clause 1 Article 4 of the Circular No.17/2023/TT-BYT, coming into force from November 9, 2023.
[7] This clause is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[8] This clause is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[9] This clause is amended according to clause 3 Article 4 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[10] This point is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[11] This clause is amended according to clause 3 Article 4 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[12] This clause is amended according to clause 3 Article 4 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[13] This Article is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[14] This Article is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[15] This Article is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[16] This point is amended according to clause 4 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[17] This point is amended according to clause 4 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[18] This point is amended according to clause 5 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[19] This point is amended according to clause 5 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[20] This point is amended according to clause 5 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[21] This Article is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[22] This point is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[23] This point is amended according to clause 6 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[24] This point is amended according to clause 6 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[25] This clause is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[26] This point is amended according to clause 7 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[27] This point is amended according to clause 7 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[28] This point is amended according to clause 8 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[29] This sentence is amended according to clause 9 Article 4 of the Circular No. 17/2023/TT-BYT , coming into force from November 09, 2023.
[30] This point is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[31] This clause is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[32] This clause is amended according to clause 10 Article 4 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[33] This point is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[34] This Article is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[35] This Chapter is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[36] This Article is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[37] This Article is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[38] This Chapter is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[39] This Article is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[40] This Article is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[41] This Article is abrogated according to point dd clause 2 Article 7 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023.
[42] Articles 9, 10 and 11 of the Circular No.17/2023/TT-BYT, coming into force from November 09, 2023, stipulate as follows:
Article 9. Terms of reference
If any legislative documents referred to in this Circular are amended, supplemented or superseded, the new ones shall apply.
Article 10. Effect
This Circular comes into force from November 09, 2023.
Article 11. Responsibility for implementation
The Chief of the Ministry Office, the Director General of the Vietnam Food Administration, the Ministry’s Chief Inspector, heads of units of and affiliated to the Ministry, Directors of provincial Departments of Health, heads of food safety authorities affiliated to provincial People’s Committees, heads of health agencies of ministries and central-government authorities, and relevant authorities, organizations and individuals are responsible for the implementation of this Circular./.
------------------------------------------------------------------------------------------------------
This translation is made by THƯ VIỆN PHÁP LUẬT, Ho Chi Minh City, Vietnam and
for reference purposes only. Its copyright is owned by THƯ VIỆN PHÁP LUẬT
and protected under Clause 2, Article 14 of the Law on Intellectual Property.Your comments are always welcomed
